FC
Foresite Capital Management IV, LLC
13F filer · CIK 0001704132Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$290MU.S. long equity reported on 13F
Positions61 new · 3 closed
Net flow last quarter+$4.56MBuys minus sells
Top 10 positions weight100.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 20266 positions | |||||
| $165M | 56.95% | 7.33% | Not reported | Q1 2021 | |
| $60.9M | 20.98% | 0.57% | +42.0% | Q4 2018 | |
| $25.4M | 8.74% | 3.59% | Not reported | Q1 2026 | |
| $23.4M | 8.06% | 0.57% | +25.0% | Q3 2020 | |
| $9.66M | 3.33% | 0.17% | Not reported | Q3 2018 | |
| CPCRNXCrinetics Pharmaceuticals, Inc. | $5.61M | 1.93% | 0.14% | Not reported | Q3 2018 |
| Q1 2026Reported May 15, 20268 positions | |||||
| $135M | 56.94% | 7.33% | Not reported | Q1 2021 | |
| $33.2M | 13.99% | 0.41% | +9.8% | Q4 2018 | |
| $20.6M | 8.67% | 3.59% | New | Q1 2026 | |
| $16.1M | 6.77% | 3.43% | Not reported | Q2 2021 | |
| $9.95M | 4.20% | 0.53% | Not reported | Q3 2020 | |
| $9.3M | 3.92% | 0.17% | Not reported | Q3 2018 | |
| $8.36M | 3.53% | 3.50% | Not reported | Q1 2019 | |
| $4.68M | 1.98% | 0.32% | -70.0% | Q1 2025 | |
| Q4 2025Reported Feb 17, 20267 positions | |||||
| $133M | 57.73% | 7.33% | Not reported | Q1 2021 | |
| $29.1M | 12.68% | 0.37% | Not reported | Q4 2018 | |
| $24.6M | 10.72% | 3.77% | Not reported | Q2 2021 | |
| $21.7M | 9.43% | 1.06% | Not reported | Q1 2025 | |
| $8.46M | 3.68% | 0.58% | Not reported | Q3 2020 | |
| $7.17M | 3.12% | 0.20% | Not reported | Q3 2018 | |
| $6.06M | 2.64% | 3.52% | Not reported | Q1 2019 | |
| Q3 2025Reported Nov 14, 20256 positions | |||||
| $119M | 65.29% | 8.79% | +8.3% | Q1 2021 | |
| $25.2M | 13.79% | 0.38% | Not reported | Q4 2018 | |
| $13.6M | 7.42% | 1.09% | -75.3% | Q1 2025 | |
| $13M | 7.12% | 4.15% | Not reported | Q2 2021 | |
| $6.42M | 3.52% | 0.21% | Not reported | Q3 2018 | |
| $5.22M | 2.86% | 0.58% | Not reported | Q3 2020 | |
Premium opens every quarter this fund has filed